Assignee
LIQMEDS WORLDWIDE LTD
GB·32 granted patents·9 pending applications·16 citations·filing 2017–2025
Top patents by PatentIndex Score
41 records- 0195US11931455B2Pharmaceutical suspension for oral dosageLIQMEDS WORLDWIDE LTD·Filed 2023·Granted Mar 19, 2024·2 cites·2 claims
- 0295US11337979B2Liquid oral formulations for sildenafilLIQMEDS WORLDWIDE LTD·Filed 2021·Granted May 24, 2022·3 cites·30 claims
- 0395US11253474B1Pharmaceutical solution of amlodipineLIQMEDS WORLDWIDE LTD·Filed 2021·Granted Feb 22, 2022·4 cites·19 claims
- 0493US12005141B2Pharmaceutical solution of amlodipineLIQMEDS WORLDWIDE LTD·Filed 2023·Granted Jun 11, 2024·1 cites·30 claims
- 0592US11723866B2Pharmaceutical solution of amlodipineLIQMEDS WORLDWIDE LTD·Filed 2022·Granted Aug 15, 2023·1 cites·30 claims
- 0691US11464778B2Liquid oral formulations for sildenafilLIQMEDS WORLDWIDE LTD·Filed 2018·Granted Oct 11, 2022·2 cites·40 claims
- 0790US12226526B2Mycophenolate oral suspensionLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Feb 18, 2025·0 cites·30 claims
- 0890US12194143B2Mycophenolate oral suspensionLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Jan 14, 2025·0 cites·30 claims
- 0990US12186322B2Liquid oral formulations for tadalafilLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Jan 7, 2025·0 cites·30 claims
- 1090US12186321B2Liquid oral formulations for sildenafilLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Jan 7, 2025·0 cites·30 claims
- 1190US11458095B2Pharmaceutical solution of amlodipineLIQMEDS WORLDWIDE LTD·Filed 2022·Granted Oct 4, 2022·1 cites·30 claims
- 1290US2026034061A1Pharmaceutical solution of amlodipineLIQMEDS WORLDWIDE LTD·Filed 2025·Application pending·0 cites
- 1389US12370136B2Aqueous suspension suitable for oral administrationLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Jul 29, 2025·0 cites·13 claims
- 1489US12226528B2Pharmaceutical solution of amlodipineLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Feb 18, 2025·0 cites·30 claims
- 1589US12097284B2Mycophenolate oral suspensionLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Sep 24, 2024·0 cites·1 claims
- 1689US12097285B2Mycophenolate oral suspensionLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Sep 24, 2024·0 cites·2 claims
- 1789US2024245688A1Liquid oral formulations for tadalafilLIQMEDS WORLDWIDE LTD·Filed 2024·Application pending·0 cites
- 1888US12005062B2Liquid oral formulations for sildenafilLIQMEDS WORLDWIDE LTD·Filed 2023·Granted Jun 11, 2024·0 cites·30 claims
- 1987US12168069B2Aqueous suspension suitable for oral administrationLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Dec 17, 2024·0 cites·13 claims
- 2087US11975006B2Liquid oral formulations for tadalafilLIQMEDS WORLDWIDE LTD·Filed 2023·Granted May 7, 2024·0 cites·28 claims
- 2186US12539300B2Method of treating seizures and epilepsy using liquid pharmaceutical composition for oral dosage of vigabatrinLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Feb 3, 2026·0 cites·10 claims
- 2286US12343338B2Ramipril solution for oral dosageLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Jul 1, 2025·0 cites·16 claims
- 2386US11918684B2Pharmaceutical composition of oral suspension of immunosuppressive agentsLIQMEDS WORLDWIDE LTD·Filed 2018·Granted Mar 5, 2024·2 cites·3 claims
- 2484US11925704B2Aqueous suspension suitable for oral administrationLIQMEDS WORLDWIDE LTD·Filed 2023·Granted Mar 12, 2024·0 cites·13 claims
- 2584US11759468B2Liquid oral formulations for sildenafilLIQMEDS WORLDWIDE LTD·Filed 2022·Granted Sep 19, 2023·0 cites·30 claims
- 2683US11666576B2Liquid oral formulations for tadalafilLIQMEDS WORLDWIDE LTD·Filed 2022·Granted Jun 6, 2023·0 cites·30 claims
- 2780US11654106B2Aqueous suspension suitable for oral administrationLIQMEDS WORLDWIDE LTD·Filed 2022·Granted May 23, 2023·0 cites·11 claims
- 2879US11382917B2Liquid oral formulations for tadalafilLIQMEDS WORLDWIDE LTD·Filed 2021·Granted Jul 12, 2022·0 cites·30 claims
- 2977US12251361B2Solutions for oral dosageLIQMEDS WORLDWIDE LTD·Filed 2023·Granted Mar 18, 2025·0 cites·7 claims
- 3075US12440441B2Pharmaceutical solution of amlodipineLIQMEDS WORLDWIDE LTD·Filed 2025·Granted Oct 14, 2025·0 cites·30 claims
- 3174US2025144013A1Mycophenolate Oral SuspensionLIQMEDS WORLDWIDE LTD·Filed 2025·Application pending·0 cites
- 3274US2024165024A1Mycophenolate oral suspensionLIQMEDS WORLDWIDE LTD·Filed 2024·Application pending·0 cites
- 3373US12551466B1Ready-to-use oral liquid formulation of clonidineLIQMEDS WORLDWIDE LTD·Filed 2025·Granted Feb 17, 2026·0 cites·23 claims
- 3468US11369567B2Aqueous suspension suitable for oral administrationLIQMEDS WORLDWIDE LTD·Filed 2017·Granted Jun 28, 2022·0 cites·5 claims
- 3568US2026060963A1Ready-to-use non-aqueous oral solution of losartanLIQMEDS WORLDWIDE LTD·Filed 2025·Application pending·0 cites
- 3665US2025345306A1Oral liquid formulation of methocarbamolLIQMEDS WORLDWIDE LTD·Filed 2025·Application pending·0 cites
- 3760US2023059869A1Oral pharmaceutical solution of clopidogrelLIQMEDS WORLDWIDE LTD·Filed 2022·Application pending·0 cites
- 3859US12390439B2Oral liquid formulation of methocarbamolLIQMEDS WORLDWIDE LTD·Filed 2025·Granted Aug 19, 2025·0 cites·20 claims
- 3957US12496291B1Ready-to-use non-aqueous oral solution of losartanLIQMEDS WORLDWIDE LTD·Filed 2025·Granted Dec 16, 2025·0 cites·10 claims
- 4039US2025177411A1Oral liquid formulation of rivaroxabanLIQMEDS WORLDWIDE LTD·Filed 2025·Application pending·0 cites
- 4139US2025177369A1Oral liquid formulation of apixabanLIQMEDS WORLDWIDE LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LIQMEDS WORLDWIDE LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →